Replies to post #458 on Outlook Therapeutics Inc (OTLK)

[DavidW2]

Could be $3-$4+ after BLA announcement.

Company said to file BLA Q1 2022. So I think it will happen in next 3 weeks.

[H2R]

Hi Thermo,

I stumbled upon this article:

https://www.healio.com/news/ophthalmology/20220131/fda-approves-vabysmo-for-treatment-of-wet-amd-dme

https://www.fiercepharma.com/pharma/nod-hand-can-genentech-roche-challenge-regeneron-s-eyela-vabysmo

I don't get answers from OTLK's IR.

Do you have a sense of the impact on the overall market (Wet AMD...) by any chance? And OTLK's potential with this new player?

Thanks!